[Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa].
This prospective study was focused on the initiation, development and outcome of nosocomial pneumonia (NP) caused by Pseudomonas aeruginosa in 51 patients receiving intensive therapy. The most characteristic features of this NP proved to be severe clinical course and poor prognosis (38% lethality). More than half of the cases developed bilateral lung disease with the predominant affection of the upper lobe in the left lung. Other frequent conditions were tissue destruction and oedema. The need of immediate hospitalization at the intensive therapy ward, septic shock, and infectious disease were predictors of fatal outcome of NP.
Baĭgozina
E A
EA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology*; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D011379:Prognosis; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D013902:Radiography, Thoracic
D000900:Anti-Bacterial Agents